PPA
OCDX

Parametric Portfolio Associates’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Parametric Portfolio Associates’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$393K Sell
21,073
-82,469
-80% -$1.48M ﹤0.01% 3190
2021
Q4 		$2.21M Buy
103,542
+39,955
+63% +$787K ﹤0.01% 2374
2021
Q3 		$1.18M Buy
63,587
+16,090
+34% +$324K ﹤0.01% 2729
2021
Q2 		$1.02M Buy
+47,497
New +$966K ﹤0.01% 2767

Other funds holding OCDX

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Parametric Portfolio Associates's OCDX Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) stake by 80% in Q1 2022, selling an estimated $1.48M and leaving 21,073 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #3190.

Parametric Portfolio Associates first reported a position in OCDX in Q2 2021 and has held it in 4 quarters since. The position peaked at $2.21M in Q4 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • Parametric Portfolio Associates held 21,073 shares of Ortho Clinical Diagnostics Holdings plc Ordinary Shares worth $393K as of Q1 2022.
  • Parametric Portfolio Associates sold 82,469 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $1.48M.
  • Ortho Clinical Diagnostics Holdings plc Ordinary Shares made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3190 holding.
  • Parametric Portfolio Associates first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and has held it in 4 quarters since.
  • Parametric Portfolio Associates's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $2.21M in Q4 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.